Prospects of stem cell therapy in osteoarthritis

被引：1
作者：
Roberts, Sally [1 ]
Genever, Paul [1 ,2 ]
McCaskie, Andrew [1 ,3 ,4 ]
De Bari, Cosimo [1 ,5 ]
机构：
[1] Arthritis Res UK Tissue Engn Ctr, Kobe, Hyogo, Japan
[2] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England
[3] Newcastle Univ, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[4] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[5] Univ Aberdeen, Musculoskeletal Programme, Sch Med & Dent, Inst Med Sci, Aberdeen AB25 2ZD, Scotland
来源：
REGENERATIVE MEDICINE | 2011年 / 6卷 / 03期
基金：
英国医学研究理事会;
关键词：
articular cartilage; bone; immunomodulatory; mesenchymal stem cell; stem cell niches; HUMAN BONE-MARROW; SPONTANEOUS MALIGNANT-TRANSFORMATION; CHONDROGENIC PROGENITOR CELLS; SYMPTOMATIC CARTILAGE DEFECTS; MESENCHYMAL STROMAL CELLS; IN-VITRO; IMMUNOMODULATORY PROPERTIES; INTERNATIONAL-SOCIETY; CROSS-CONTAMINATION; TELOMERASE ACTIVITY;
D O I：
10.2217/RME.11.21
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Osteoarthritis is a common disorder in which there is not only extensive degeneration but also an aberrant attempt at repair in joints. Stem cell therapy could provide a permanent, biological solution, with all sources of stem cells (embryonic, fetal and adult) showing some degree of potential. Mesenchymal stromal/stem cells, however, appear to be the leading candidates because of their ability to be sourced from many or all joint tissues. They may also modulate the immune response of individuals, in a manner influenced by local factors. This biological behavior of stem cells renders the application of regulatory standardizations challenging in comparison to pharmaceutical therapies. However, this would not be an issue if endogenous stem cells were activated to effect repair of an arthritic joint.
引用
收藏
页码：351 / 366
页数：16
相关论文
共 152 条
[11]  
Bianco P, 2010, HUM GENE THER, V21, P1057, DOI 10.1089/hum.2010.136
[12]   ISOLATION AND CULTURE OF INNER CELL MASS CELLS FROM HUMAN BLASTOCYSTS [J].
BONGSO, A ;
FONG, CY ;
NG, SC ;
RATNAM, S .
HUMAN REPRODUCTION, 1994, 9 (11) :2110-2117
[13]   Polycomb complexes repress developmental regulators in murine embryonic stem cells [J].
Boyer, LA ;
Plath, K ;
Zeitlinger, J ;
Brambrink, T ;
Medeiros, LA ;
Lee, TI ;
Levine, SS ;
Wernig, M ;
Tajonar, A ;
Ray, MK ;
Bell, GW ;
Otte, AP ;
Vidal, M ;
Gifford, DK ;
Young, RA ;
Jaenisch, R .
NATURE, 2006, 441 (7091) :349-353
[14]   TREATMENT OF DEEP CARTILAGE DEFECTS IN THE KNEE WITH AUTOLOGOUS CHONDROCYTE TRANSPLANTATION [J].
BRITTBERG, M ;
LINDAHL, A ;
NILSSON, A ;
OHLSSON, C ;
ISAKSSON, O ;
PETERSON, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (14) :889-895
[15]   MESENCHYMAL STEM-CELLS [J].
CAPLAN, AI .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) :641-650
[16]   Mesenchymal stem cells: building blocks for molecular medicine in the 21st century [J].
Caplan, AI ;
Bruder, SP .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (06) :259-264
[17]   Mesenchymal Stem Cells: The Past, the Present, the Future [J].
Caplan, Arnold I. .
CARTILAGE, 2010, 1 (01) :6-9
[18]   Safety and Complications Reporting on the Re-implantation of Culture-Expanded Mesenchymal Stem Cells using Autologous Platelet Lysate Technique [J].
Centeno, Christopher J. ;
Schultz, John R. ;
Cheever, Michelle ;
Robinson, Brent ;
Freeman, Michael ;
Marasco, Wayne .
CURRENT STEM CELL RESEARCH & THERAPY, 2010, 5 (01) :81-93
[19]   Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing [J].
Chamberlain, Giselle ;
Fox, James ;
Ashton, Brian ;
Middleton, Jim .
STEM CELLS, 2007, 25 (11) :2739-2749
[20]   Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells [J].
Chambers, I ;
Colby, D ;
Robertson, M ;
Nichols, J ;
Lee, S ;
Tweedie, S ;
Smith, A .
CELL, 2003, 113 (05) :643-655
12345678910